Abstract Introduction: Hepatitis C virus (HCV) is frequently associated with rheumatic autoimmune manifestations including rheumatoid-like arthritis.
Introduction
Hepatitis C virus (HCV) infection is a global public health problem affecting 3% of the population worldwide, i.e., about 180 million people [1] . Egypt has the highest prevalence of HCV infection reaching 14.7% according to the most recent Egyptian Demographic Health Survey (EDHS) released in 2009 [2] . Infection with HCV causes acute and chronic hepatitis with attending sequelae of cirrhosis, hepatocellular carcinoma and various extrahepatic manifestations [3] . Several extrahepatic manifestations, many of which are autoimmune in nature, have been described in association with HCV infection among which, mixed cryoglobulinemia has the strongest association [4] [5] [6] . Additional HCV-related immunologic complications include autoantibody production, rheumatologic disorders, lichen planus, immune mediated cytopenias and lymphoproliferative disorders [4] . Among the different clinical disorders associated with HCV infection, articular involvement is a frequent complication, and the clinical picture of HCV-related arthropathy varies widely ranging from polyarthralgia to monoarticular or oligoarticular intermittent arthritis and symmetric chronic polyarthritis. Monoarticular or oligoarticular involvement affects larger joints and is typically associated with mixed cryoglobulinemia, whereas symmetric polyarthritis associated with HCV infection frequently displays a rheumatoid arthritis (RA) like clinical picture [7, 8] . HCV-related symmetric polyarthritis, in comparison to RA however, is generally less aggressive, non-nodular, nondeforming, non-erosive and negative for antibodies against cyclic citrullinated peptides (anti-CCP) [9, 10] . It has been suggested that, in genetically susceptible individuals, HCV can trigger RA [11, 12] . Searching for a causal link between HCV infection and RA, several authors tested sera from RA patients for HCV-Ab with conflicting results [13] [14] [15] [16] [17] .
The aim of the present work was to determine the prevalence and clinical significance of HCV infection among rheumatoid arthritis patients.
Patients and methods
This study included one hundred and ten RA patients attending the outpatient clinic of the Rheumatology and Rehabilitation Department, Faculty of Medicine, Cairo University, between July 2009 and July 2010, and was carried out in accordance with the guidelines of the World Medical Association (Declaration of Helsinki). All RA patients fulfilled the ACR 1987 revised criteria for the classification of RA [18] .
Patient assessment
All patients included in this study were subjected to full history taking and clinical examination. Routine laboratory tests included complete blood count (CBC), erythrocyte sedimentation rate (ESR), serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), albumin, urea, creatinine and urine analysis. Serum rheumatoid factor (RF) was assayed with a quantitative immunonephelometry test (Behring, Marburg, Germany). RF was considered to be positive when the concentration was higher than the cut-off value of the kit (15 IU/ml). Antibodies to cyclic citrullinated peptides (anti-CCP) were measured using the microparticle enzyme immunoassay (MEIA) method with the Abbott AxSym (Chicago, IL, USA). Normal reference level is up to 5 U/ml. Anti-nuclear antibodies (ANA) were detected by indirect immunofluorescence. Abdominal ultrasonography was done for all patients. Disease activity was determined by the 28 joint count (DAS28) [19] . A modified Larsen score was used for assessment of radiological damage in plain radiographs of the hands and feet [20] . The Modified Health Assessment Questionnaire (MHAQ) was used for measuring the functional ability of the patients [21] .
Diagnosis of HCV infection
All patients were screened for the presence of HCV-Ab in serum using a Microparticle Enzyme Immunoassay (MEIA) test, with the Abbot AxSYM (Chicago, IL, USA). Patients positive for HCV-Ab were further tested for the presence of HCV RNA using a quantitative reverse transcriptase polymerase chain reaction technique (RT-PCR), (Promega Co., Madison, WI, USA). The detection limit was 100 IU/ml; weak viremia < 100.000, moderate viremia (>100.000-1000.000 IU/ml), severe viremia > 1000.000 IU/ml.
Statistics: Data were statistically described in terms of range, mean ± standard deviation (±SD), median, frequencies (number of cases) and percentages when appropriate. Comparisons were done using Mann Whitney U test, Chi square (v 2 ) test and exact test where appropriate. A probability value (p-value) less than 0.05 was considered statistically significant. All statistical calculations were done using the computer program SPSS (Statistical Package for the Social Science; SPSS Inc., Chicago, IL, USA) version 15 for Microsoft Windows.
Results

Demographic data of studied patients
This study included 110 patients with RA, 97 patients were females (88.2%) and 13 were males (11.8%). Their ages ranged from 20 years to 70 years with a mean of 44.6 ± 12.7 years. Their disease duration ranged from 5 months to 34 years with a mean of 7.92 ± 6.56 years. Eighty-seven patients were receiving Methotrexate, 66 patients antimalarials, 48 low dose oral prednisone, 26 Leflunomide and 8 Sulfasalazine.
Prevalence and risk factors for HCV infection
HCV antibody was detected in 22 of 110 RA patients (20%). Among the HCV-Ab positive group, fifteen patients were females and seven were males. Identified risk factors for HCV transmission were blood transfusion in 4 patients, surgical exposure in 8 patients and infected spouse in one patient. HCV infection was diagnosed in nine patients (40.9%) for the first time in the present study. Thirteen patients (59.1%) were previously diagnosed to have HCV infection with a duration ranging from 1.5 to 7 years (mean 3.07 ± 1.70). RA was diagnosed prior to HCV detection in those patients and they were investigated for HCV infection because of elevated liver enzymes. Two patients (9.1%) had received interferon plus ribavirin combination therapy, but one of them discontinued antiviral therapy due to flare of RA and the other patient did not respond to antiviral therapy.
The prevalence of HCV antibody was studied among different age groups (from 20 to 40 years, from 40 to 60 years and >60 years). Patients older than 60 years had the highest prevalence of positive HCV-Ab (p = 0.021), Table 1 .
Among the 22 HCV-Ab positive patients 14 (63.6%) had positive viremia as detected by PCR. Viral load was mild in 7, moderate in 5 and severe in 2 patients.
ALT levels and liver cirrhosis in HCV-Ab positive patients
Persistently elevated liver enzymes were found in 4/22 HCV-Ab positive patients (18.2%). Among those, 3 patients were positive for HCV-RNA, i.e. only 3/14 patients with detectable viremia had elevated ALT levels above the normal reference range. Mean ALT levels were not statistically significantly different between HCV-Ab positive and -negative RA groups (30.41 ± 35.23 versus 19.4 ± 9.79 U/l, respectively, p = 0.12). Liver cirrhosis was detected in 4/22 (18.2%) HCV-Ab positive patients by abdominal ultrasonography. Only one of the 4 cirrhotic cases had elevated ALT. All 4 cases with liver cirrhosis had detectable viremia, i.e., 4/14 (28.6%) patients with positive PCR had liver cirrhosis.
3.4. Impact of HCV viremia on disease activity and functional state in HCV-Ab positive RA patients DAS28, MHAQ, anti-CCP and RF titers were compared between HCV-Ab positive patients with undetectable, mild, moderate or severe levels of viremia; no statistically significant differences were detected (Table 2) .
3.5.
Comparison between HCV-Ab positive and -negative patients 3.5.1. Characteristics of arthritis All patients included in this study had symmetric polyarthritis. HCV-Ab positive patients were significantly older, more frequently male and had a longer disease duration than HCVAb negative patients (p = 0.00, 0.001 and 0.02, respectively). HCV-Ab positive patients had also significantly more frequent deformities and higher MHAQ scores (p < 0.005 and 0.002, respectively). The frequency of erosions and modified Larsen's scores, however, were not significantly different between both groups. DAS 28 scores were also not statistically significantly different between both groups (Table 3) , HCV-Ab positive patients, however, had significantly higher ESR than HCV-Ab negative ones (59.18 ± 27.8 versus 44.57 ± 27.2 mm/h, p = 0.02).
The effect of patient age and disease duration on obtained results is shown later (Tables 5 and 6 ).
Autoantibody frequencies
No statistically significant differences were found in the frequencies of RF, ANA and anti-CCP between HCV-Ab positive and -negative patient groups (Table 3) .
Extraarticular manifestations in RA patients
There were no statistically significant differences between both groups in the frequency of subcutaneous nodules, ocular manifestations, dry mouth, lymphadenopathy, splenomegaly, interstitial pulmonary fibrosis (IPF), peripheral neuropathy or Raynaud's phenomenon.
HCV-Ab positive RA patients had significantly more frequent hepatomegaly (p < 0.001) and vasculitis in the form of mononeuritis multiplex in 1 patient or palpable purpura in 3 patients (p < 0.001) ( Table 4) . 
Effect of patient age on the clinical picture in RA patients
To study the possible confounding effect of age on DAS28, MHAQ, vasculitis, and hepatomegaly, these parameters were compared between different age groups. No statistically significant differences were found in DAS28 and MHAQ with increasing age. There was a trend towards an increase in the frequency of deformities with increasing age without reaching statistical significance. The frequencies of vasculitis and hepatomegaly were highest in the age group P 60 years (p = 0.02 and 0.004, respectively (Table 5) .
Effect of disease duration on the clinical picture in RA patients
To study the contribution of disease duration on the clinical picture in RA, patients were divided into three groups according to disease duration (Table 6 ). There was a statistically significant increase in the frequency of deformities, erosive arthritis and modified Larsen scores with increasing disease duration (p < 0.001, p = 0.003 and 0.002, respectively). The frequency of hepatomegaly was significantly associated with increasing disease duration (p = 0.003). MHAQ scores and the frequency of vasculitis were not statistically significantly different between patient groups with different disease duration. It can be concluded that the significantly higher MHAQ score in HCV-Ab positive RA patients (p = 0.002) is independently associated with HCV infection irrespective of the age group and disease duration and is not affected by the level of viremia (Tables 2, 3 , 5 and 6).
Discussion
The significance of HCV infection in RA patients remains unclear. While HCV -Ab were detected with higher frequency than in the general population in sera of RA patients in studies from Spain and Italy [13, 14] , other studies failed to confirm this association [15] [16] [17] 22, 23] . Detection of serum anti-HCV antibodies is indicative of past or active infection. HCV viremia as assessed by RT-PCR is a much more powerful indicator of chronic hepatitis due to the virus [24] . In the present study, the prevalence of HCV-Ab among RA patients was 20%, higher than the reported 14.7% prevalence in Egypt according to the Egyptian Demographic Health Survey (EDHS) [2] , which is in agreement with some authors [13, 14] . HCV-RNA was found in 14/22 (63.6%) HCV-Ab positive RA patients as compared to the 67% prevalence of active viremia in HCV-Ab positive individuals in the EDHS [2] . Blood transfusion, hospital admission, exposure to invasive medical procedures e.g. gastrointestinal endoscopies and surgeries and repeated injections are identified risk factors for HCV transmission in Egypt [25] . RA patients are frequently exposed to these risk factors and thus may present a high risk group for HCV infection. Besides, although HCV can cause arthritis fulfilling the classification criteria for RA [18] in many patients, generally being non-erosive [7, 8] , erosions have been reported in 7/23 patients with chronic hepatitis presenting with symmetric polyarthritis [12] . Therefore, the possibility that some cases with HCV-related arthritis could have been included among the studied RA patients cannot be excluded.
In the studied HCV infected RA patients, a higher male/female ratio and higher frequency of HCV-Ab were found with increasing age reflecting the characteristics of HCV infection in Egypt [2, [25] [26] [27] . Guennoc et al. [23] found significantly higher levels of transaminases among HCV-Ab positive RA patients, however, in the present study, mean ALT levels were not significantly different between HCV-Ab positive and -negative patients.
Approximately 25-30% of patients with chronic HCV infections have persistently normal ALT levels and are usually referred to as healthy carriers of HCV [28, 29] . In the present study, the majority of HCV-infected patients had within normal ALT levels (82% of HCV-Ab positive and 79% of HCV-RNA positive RA patients), which is in agreement with Guennoc et al. [23] , who found only 2/7 HCV-Ab positive RA patients to have elevation of serum transaminases above the normal reference ranges. Therefore, it is recommended to screen RA patients for HCV infection before initiating immunosuppressive or hepatotoxic drugs.
DAS28, as a measure of disease activity in RA, may increase with age as ESR is one of its components [30] . No statistically significant difference was found in DAS28 between HCV-Ab positive and -negative RA groups although HCVAb positive patients were significantly older (p < 0.001) and had significantly higher ESR (p = 0.02). Furthermore, in the studied patients, DAS28 was not significantly different between RA patients in different age groups. A possible explanation for the elevated ESR in HCV-Ab positive patients is the host response to HCV infection [31] . Guennoc et al. [23] , however, found no difference in ESR or C-reactive protein between HCV-Ab positive and -negative RA patients. Rheumatoid factor and more recently, anti-CCP titers have been found to correlate with disease activity in RA [32, 33] . Along with DAS28, RF and anti-CCP titers were not statistically significantly different between HCV-Ab positive RA patients with undetectable, mild, moderate or severe levels of viremia, suggesting that co-existing HCV infection has no effect on RA disease activity. MHAQ scores were also not significantly different between HCV-Ab positive patients with different levels of viremia.
In the studied patients, no statistically significant differences were found in the frequency of erosive arthritis, subcutaneous nodules or anti-CCP positivity between HCV-Ab positive and -negative RA groups, suggesting that the studied HCV-Ab positive patients had RA with co-existing HCV infection rather than HCV-related arthritis [7, 9, 10] . In agreement with our results, Guennoc et al. [23] , did not find a significant difference in the frequency of anti-CCP between HCV-Ab positive and -negative RA patients. RF can be detected in 75-85% of patients with RA and in 37.5% in patients affected by HCV presenting with polyarthritis [9] . Antinuclear antibodies (ANA) can be found in 8-54% of HCV infected individuals [34, 35] while in RA, ANA can be present in 20-30% of patients [36] . In the studied patients, the frequencies of RF and ANA were not statistically significantly different between HCV-Ab positive and -negative RA patients.
A longer disease duration in RA is associated with more structural damage and loss of mobility [37] . This was confirmed in the present study where increasing disease duration was significantly associated with higher frequency of deformities, erosive arthritis and modified Larsen's scores (p < 0.001, p = 0.003, p = 0.002, respectively). HCV-Ab positive patients had higher, although not statistically significant modified Larsen's scores but significantly more frequent deformities as compared to HCV-Ab negative ones (p < 0.005), which may be explained by the longer disease duration in HCV-Ab positive patients (p = 0.02).
Disability in RA increases gradually with age and increasing disease duration [38] , however, in the present study, no statistically significant differences were found in MHAQ scores in patient groups with different age and disease duration. Higher MHAQ scores were found in HCV-Ab positive RA patients, suggesting that HCV infection is independently associated with physical disability in RA. In agreement with our results, HCV seropositive patients, in the absence of advanced liver disease have been shown to have diminished physical function as a part of health related quality of life assessment [39] . In the present study, however, MHAQ was not significantly different between HCV-Ab positive patients with different levels of viremia.
Vasculitis is a relatively uncommon extraarticular manifestation of RA affecting less than 5% of RA patients, typically affecting late middle aged persons with severe RA and long disease duration [40] . In the present study, there was a higher incidence of vasculitis in age groups older than 40 years (p = 0.02) but no association with longer disease duration.
HCV infection may be associated with a systemic vasculitis with or without mixed cryoglobulinemia [41] . In the HCV-Ab positive RA group 4/22 HCV-Ab positive patients had vasculitis which was significantly more frequent than in HCV-Ab negative patients (p < 0.001). This is in agreement with Ramos-Casals et al. [42] who found a significantly higher frequency of vasculitis among patients with systemic autoimmune diseases and HCV infection than in those without co-existing HCV infection. In agreement with Ramos-Casals et al. [42] , no statistically significant differences were found in the frequency of sicca features, Raynaud's phenomenon, lung involvement, peripheral neuropathy between HCV-Ab positive and -negative RA groups.
Overt clinical evidence of liver disease in rheumatoid arthritis is considered generally absent, although hepatomegaly has been reported in 22% of RA patients by scintigraphic scanning [43] . Hepatic dysfunction in RA is associated with disease severity and longer disease duration [44] . In this study, a statistically significantly higher frequency of hepatomegaly was found in HCV-Ab positive patients as compared to the HCV-Ab negative group (p < 0.001), in agreement with Ramos-Casals et al. [42] . Hepatomegaly was associated with older age (p = 0.004) and longer disease duration (p = 0.003).
In conclusion, HCV infection is common among Egyptian RA patients. Most patients with active viremia have normal liver enzymes, indicating the necessity for routine screening of RA patients for HCV infection in Egypt. Although the presence of HCV infection has no impact on the disease activity or severity in RA, it is associated with significant disability as well as comorbidities in the form of hepatomegaly and vasculitis which were associated with older age. Hepatomegaly was also associated with longer disease duration.
